07 Jan 2001

Tavegil® (Tavegil® Sirup) - Deutschland

Updated: 07 Jan 2001

Tavegil®

Allergien, Pruritus. Parenterale Anw.: Akute Allergien, Adjuvans bei anaphylaktischem Schock und Quincke-Ödem, Prophylaxe von Kontrastmittelallergien und histaminbedingter Komplikationen in d. Anästhesie in Komb. mit einem H2-Rezeptorantagonisten sowie zur Prophylaxe allg. Nebenw. in der Magenfunktionsdiagnostik (Histaminprobe).

Tavegil® Description, Presentation and Dosage

Tavegil® Description

Tavegil® Drug Class Description

Einzelstoffe

Tavegil® Drug Description

10 ml enth.: Clemastinhydrogenfumarat 0,67 mg (entspr. 0,5 mg Base).

Tavegil® Generic Name

Tavegil® Sirup

Tavegil® Presentation

Tavegil® Presentation

Tavegil®

Tavegil® Manufacturer

Novartis Consumer Health

Related Learning Zones

Cystic Fibrosis Knowledge Centre

Cystic Fibrosis Knowledge Centre

Cystic fibrosis (CF) is a genetic condition caused by a defect in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel. The Cystic Fibrosis Knowledge Centre provides healthcare professionals with access to disease awareness information, emerging and established treatment options and current best practice based on recently updated guidelines by the European Cystic Fibrosis Society (ECFS). A resources section contains external links to upcoming medical conferences and patient support groups.

This resource is developed by EPG Health Media for epgonline.org, supported by an independent educational grant from Vertex.

Prostate Cancer Learning Hub

Prostate Cancer Learning Hub

The Prostate Cancer Learning Hub has been designed with the busy healthcare professional in mind. The resource conveniently organises a range of up-to-date education content, reference materials and decision support tools, all focussing on prostate cancer. The disease awareness section provides you with access to a Prostate Cancer Knowledge Centre, which has been developed to provide you with easy to digest best practice guidance for the treatment and management of patients with prostate cancer.

Tavegil® Dosage

Tavegil® Adult Dosage

Parabene E 214 6 mg, E 216 4 mg, Sorbitol 3,5 g, Kaliumdihydrogenphosphat, Natriummonohydrogenphosphat, Saccharin-Natrium, Propylenglycol, Aromastoffe.

Tavegil® Child Dosage


Tavegil® Tabletten
Zus.: 1 Tbl. enth.: Clemastinhydrogenfumarat 1,34 mg (entspr. 1 mg Base).
Weit. Bestandteile: Magnesiumstearat, Povidon, Talkum, Lactose.

Tavegil® Injektionslösung i.v., i.m.
Zus.: 1 Amp. (5 ml) enth.: Clemastinhydrogenfumarat 2,68 mg (entspr. 2 mg Base).
Weit. Bestandteile: Ethanol 140 mg, Sorbitol 90 mg, Natriumcitrat, Natriumchlorid, Propylenglycol, Wasser.

Tavegil® Elderly Dosage

10 ml entspr. 0,29 BE.

Tavegil® Precautions, Reactions and Contraindications

Tavegil® Special Precautions

Tavegil® Special Precautions

A 104, Z 3

Tavegil® Adverse Reactions

Tavegil® Adverse Reactions

Strenge Ind.-Stellung Gr 1 .

Related Drugs - Ear, Nose and Throat

Back to top